POST Online Media Lite Edition


EU to purchase up to 300 mln doses of BioNTech Pfizer vaccine

Christian Fernsby |
The European Union (EU) will authorize a contract for the purchase of up to 300 million doses of the coronavirus vaccine jointly developed by German company BioNTech and its American partner Pfizer.

Article continues below


The contract, due to be reached, will be the fourth one the EU secures with a pharmaceutical company to buy vaccines for coronavirus.

The BioNTech Pfizer vaccine candidate has proved to be more than 90 percent effective in preventing coronavirus infection in participants with no proven previous SARS-CoV-2 infection, the two companies announced on Monday.

What to read next

Russian supersonic business jet SBJ can have flight range up to 8,000 km
Alvora with partner to build Poland-Lithuania gas pipeline
Russia biggest lender Sberbank hit with corporate raiding lawsuit in U.S.